|Mauna Kea Technologies SA -- France Stock|| |
EUR 3.13 0.06 1.95%
Founder, CEO and Director
Mr. Sacha Loiseau is Chief Executive Officer and Board Member of Mauna Kea Technologies SAS. He founded Mauna Kea Technologies in May 2000 and was the CEO ever since. In July 2011, he successfully led the company to an initial public offering on the NYSE Euronext Paris index. He started his career at the National Center for Space Studies in Toulouse and at the Paris Observatory, then joined NASA Jet Propulsion Laboratory in Pasadena, California, as a research scientist. He is a graduate of the Ecole Polytechnique in Paris and has a Ph.D. in Astrophysics and Optical Instrumentation.
33 1 48 24 03 45 http://www.maunakeatech.com
The company has return on total asset (ROA)
of (35.99) %
which means that it has lost $35.99 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE)
of (123.6) %
meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 6.82 M in total debt with debt to equity ratio (D/E) of 83.4 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Mauna Kea Technologies SA has Current Ratio of 3.35 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.
Mauna Kea Technologies SA, a medical device company, develops and sells endomicroscopy and optical biopsy for the diagnosis and treatment of cancer and other diseases. The company was founded in 2000 and is headquartered in Paris, France. Mauna Kea operates under Medical Appliances Equipment classification in France and traded on Paris Stock Exchange exchange. It employs 81 people.Mauna Kea Technologies SA (MKEA) is traded on Paris Stock Exchange in France. It is located in 9, rue d'Enghien and employs 81 people.